Sold as Ultracet. Every FDA application for this active ingredient: 1 branded and 11 generic.
As of Nov 16, 2026, FDA lists 12 applications for Acetaminophen; Tramadol Hydrochloride (sold as Ultracet), first approved Aug 15, 2001, with 0 new uses approved and 0 published complete response letters.
| Nephrostomy Tract Infiltration for Pain Control After PCNLPostoperative Pain, Kidney Calculi · Hitit University | Not applicable | Recruiting | Jul 23, 2026 |
| Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active LaborLabor Pain · Universidad Nacional Autonoma de Honduras | Phase 4 | Recruiting | Feb 27, 2026 |
| Opioid-Free Pain Protocol After Shoulder ArthroplastyShoulder Arthropathy, Shoulder Pain · Henry Ford Health System | Phase 4 | Active, not recruiting | Aug 5, 2022 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA